NTLA stock has surged 35% overnight ahead of a phase 3 readout for a gene-editing therapy. Other stocks, including ASTS, QCOM, INTC, AMD, POET, and Nio, have also seen notable movements, with some reaching 52-week highs. The market appears to be experiencing a rally, with various factors driving the increases, although some investors are expressing caution about certain stocks.